Intelligene (7832.TWO)
- Previous Close
11.50 - Open
11.55 - Bid 11.00 x --
- Ask 11.10 x --
- Day's Range
10.95 - 11.55 - 52 Week Range
4.73 - 16.70 - Volume
212,475 - Avg. Volume
1,503,689 - Market Cap (intraday)
6.409B - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-0.30 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Intelligene Inc. engages in the development of RNA gene therapy drugs for infectious diseases. The company uses siRNA based drugs to develop the treatment of pandemics and influenza. The company was founded in 2023 and is headquartered in Taipei, Taiwan.
www.intelli-gene.comRecent News: 7832.TWO
View MorePerformance Overview: 7832.TWO
Trailing total returns as of 5/29/2025, which may include dividends or other distributions. Benchmark is TSEC CAPITALIZATION WEIGHTED ST (^TWII) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 7832.TWO
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 7832.TWO
View MoreValuation Measures
Market Cap
6.38B
Enterprise Value
5.67B
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.36k
Price/Book (mrq)
9.60
Enterprise Value/Revenue
3.19k
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
--
Net Income Avi to Common (ttm)
--
Diluted EPS (ttm)
-0.30
Balance Sheet and Cash Flow
Total Cash (mrq)
--
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
--